Glybera Cures Untreatable Genetic Disorders



technology innovation, Glybera, future medical technology, lipoprotein lipase deficiency, LPLD, DNA, genetic disease, Europe, medical technology, future medicine
Has anybody of you ever thought of the fact, that even the simplest mutation or mis-coding in a gene may cause a serious problem? The innovative drug, Glybera, has been developed to treat a genetic disorder called lipoprotein lipase deficiency (LPLD). More than 1,000,000 people around the world suffer from this genetic disease, caused by a mutated gene that prevents people from making the enzymes necessary to properly metabolize fatty acids in their blood, leading to severe abdominal pain, diarrhea, and acute (and sometimes fatal) pancreatitis. Glybera goes in and modifies your DNA directly, using a deactivated virus to deliver new genetic code into cells, teaching them to properly produce the fat-metabolizing enzymes that they’ve been missing. This drug has been recently approved for use outside of a research hospital or clinical trial, so people will get a possibility to take it in 2013. Of course, Glybera will be very expensive: a series of one-time injections into a patient’s leg muscles will cost insurance companies in Europe $1.6 million per dose. Don’t forget, it’s a new generation of drugs that can treat diseases that were untreatable until now.
Via:dvice.com

Donate BTC: 1DUUZbiqjbJvzjuRZEwTS47bqgmnhEJ4XG

Donate ETH: 0x981FcEAAa895C6cee76D2876e9AfC649Dc0C4c75

More Posts:

Smart Buildings - The Future Of Building Technology
Stack Car By Michelin For 2046
Football Theme Park On An Artificial Archipelago In The UAE
Exotic Way Of Food Dishing
QBotix Solar Tracking System
NASA’s Game Changing Technology Development Program
3Doodler Pen Will Let Laymen Experiment With 3D Printing (+VIDEO)
Nicholas Negroponte: Nanobots in Your Brain Could Be the Future of Learning
Sion - A Solarcar For Everyone
World’s First Thorium Molten Salt Experiment in over 45 Years